CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
Authors
Keywords
Pancreatic cancer, CD133, Epithelial-mesenchymal transition (EMT), ERK1/2, N-cadherin, Cancer metastasis
Journal
Molecular Cancer
Volume 13, Issue 1, Pages 15
Publisher
Springer Nature
Online
2014-01-27
DOI
10.1186/1476-4598-13-15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
- (2013) B. G. Hollier et al. CANCER RESEARCH
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA
- (2012) Xiangyi He et al. CARCINOGENESIS
- Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway
- (2012) Kiran Kumar Velpula et al. CELLULAR SIGNALLING
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy
- (2012) Sonshin Takao et al. Journal of Hepato-Biliary-Pancreatic Sciences
- RAF/MEK Dependence of KRAS -Mutant Pancreatic Ductal Adenocarcinomas: Figure 1.
- (2012) Aphrothiti J. Hanrahan et al. Cancer Discovery
- Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer
- (2011) Yu-Syuan Chen et al. PLoS One
- Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer
- (2011) Qiang Ding et al. Human Cell
- Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study
- (2010) Deuk Chae Na et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases
- (2009) Dominique Boivin et al. BIOCHEMISTRY
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
- (2008) N. Dumont et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now